www.stirlingproducts.net
Stirling Products (ASX:STI) is a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products for its own interests as well as on a contractual basis for third parties. Strategically, Stirling Products is positioned to capitalise on the rapidly changing conditions within the global pharmaceutical and health markets.
The Stirling Products corporate headquarters are in Sydney, Australia and its North American pharmaceutical manufacturing operations are based on Cape Breton, Nova Scotia, Canada.
Stirling operates through three main business units each managed by proven industry specialist managers:
- Pharmaceutical & Healthcare
- Research & Development
- Animal Products
Stirling Products' TeleMedCare units in major UK pharmacy pilot trial
A pilot trial of Stirling Products' (ASX:STI) TeleMedCare telemedicine units is underway within two flagship stores of one of the largest pharmacy chains in the United Kingdom.
The pilot phase, to be concluded within two months is designed to assess the effectiveness and benefits of the multi-awarded TeleMedCare units from a client, clinical & commercial perspective.
If successful, Stirling expects TeleMedCare would be incorporated in a major UK national roll-out of specialist health clinics within many of the UK pharmacies. There are over 4,000 pharmacies in the UK and internationally in the chain.
Six TeleMedCare fully interactive monitoring and diagnostic units have been purchased for the pilot program, which has a further two months to run.
On successful deemed completion of the pilot program, a formal roll-out agreement would be expected to be executed between the parties.


















